chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 23.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Feeling abnormal, Laboratory test, Loss of consciousness, Nausea, Pain
Clinical narrative: The day I got the vaccine I had been having health problems. I had been having withdrawal from one of my medications and I had lost weight.  Right away after the shot I passed out and when I came to, I threw up a couple of times. I was taken to the ER and I had low potassium levels were low, but all other tests were normal. I had some aches pains and feverishness for a couple of days. Five days after the vaccine I had bad diarrhea several times a day. I was nauseous and feeling bad. I had an appointment with my GI doctor a week later but I had to go to the ER before that. They did not find anything in most tests. The next day I tested positive for CDIFF. I was prescribed antibiotics. I went back to the ER a third time because the Vancomycin prescription had caused severe nausea. I am still feeling bad after six weeks but it has gotten better.
Age: 23.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia, Urine analysis, Vomiting
Clinical narrative: The day I got the vaccine I had been having health problems. I had been having withdrawal from one of my medications and I had lost weight.  Right away after the shot I passed out and when I came to, I threw up a couple of times. I was taken to the ER and I had low potassium levels were low, but all other tests were normal. I had some aches pains and feverishness for a couple of days. Five days after the vaccine I had bad diarrhea several times a day. I was nauseous and feeling bad. I had an appointment with my GI doctor a week later but I had to go to the ER before that. They did not find anything in most tests. The next day I tested positive for CDIFF. I was prescribed antibiotics. I went back to the ER a third time because the Vancomycin prescription had caused severe nausea. I am still feeling bad after six weeks but it has gotten better.
Age: 36.0
Sex: F
Vaccine: UNK, COVID19
Symptoms: Injection site induration, Injection site mass, Injection site pain, Injection site pruritus, Injection site swelling
Clinical narrative: the injection site on her left arm was hard to the touch and has bruises; the injection site on her left arm was hard to the touch and has bruises; menstrual cycle and symptoms came earlier and heavier; menstrual cycle and symptoms came earlier and heavier; Second dose: the injection site on her left arm got really, really big, itchy, and it was hot to the touch; Second dose: the injection site on her left arm got really, really big, itchy, and it was hot to the touch; second dose of Pfizer-BioNTech COVID-19 Vaccine injection when area started getting red; This is a spontaneous report from a contactable consumer reporting for herself. A 36-year-old female patient receive second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration at the age of 36 years old on 08Apr2021 10:45 (Lot Number: EW0151, Expiration Date: 11Apr2021) on Left arm at single dose for COVID-19 immunization. Medical history was reported as none. Ongoing concomitant medications included curcuma longa (TURMERIC), fish oil (OMEGAN) and zinc, all as Herbal supplement. Historical Vaccine included first dose of BNT162B2 (lot number EN6207) at the age of 36 years old on 18Mar2021 on Left arm for COVID-19 immunization and experienced chills and injection site pain of the left arm. The patient reported that after that second dose her menstrual cycle and symptoms came earlier and heavier on 09Apr2021. She also reported that the injection site on her left arm got really, really big, itchy, and it was hot to the touch on 08Apr2021. Starting today (13Apr2021) the injection site on her left arm was hard to the touch and has bruises. She asked if these adverse events were normal. It was also reported onset was around 2-3 hours after she was administered the second dose of Pfizer-BioNTech COVID-19 Vaccine injection when area started getting red on 08Apr2021. The affected area got smaller and smaller. The outcome of events vaccination site pruritus, vaccination site warmth, vaccination site erythema were resolving while outcome of other events were unknown.   No follow-up attempts are needed. No further information is expected.
Age: 36.0
Sex: F
Vaccine: UNK, COVID19
Symptoms: Injection site warmth
Clinical narrative: the injection site on her left arm was hard to the touch and has bruises; the injection site on her left arm was hard to the touch and has bruises; menstrual cycle and symptoms came earlier and heavier; menstrual cycle and symptoms came earlier and heavier; Second dose: the injection site on her left arm got really, really big, itchy, and it was hot to the touch; Second dose: the injection site on her left arm got really, really big, itchy, and it was hot to the touch; second dose of Pfizer-BioNTech COVID-19 Vaccine injection when area started getting red; This is a spontaneous report from a contactable consumer reporting for herself. A 36-year-old female patient receive second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration at the age of 36 years old on 08Apr2021 10:45 (Lot Number: EW0151, Expiration Date: 11Apr2021) on Left arm at single dose for COVID-19 immunization. Medical history was reported as none. Ongoing concomitant medications included curcuma longa (TURMERIC), fish oil (OMEGAN) and zinc, all as Herbal supplement. Historical Vaccine included first dose of BNT162B2 (lot number EN6207) at the age of 36 years old on 18Mar2021 on Left arm for COVID-19 immunization and experienced chills and injection site pain of the left arm. The patient reported that after that second dose her menstrual cycle and symptoms came earlier and heavier on 09Apr2021. She also reported that the injection site on her left arm got really, really big, itchy, and it was hot to the touch on 08Apr2021. Starting today (13Apr2021) the injection site on her left arm was hard to the touch and has bruises. She asked if these adverse events were normal. It was also reported onset was around 2-3 hours after she was administered the second dose of Pfizer-BioNTech COVID-19 Vaccine injection when area started getting red on 08Apr2021. The affected area got smaller and smaller. The outcome of events vaccination site pruritus, vaccination site warmth, vaccination site erythema were resolving while outcome of other events were unknown.   No follow-up attempts are needed. No further information is expected.
Age: 36.0
Sex: F
Vaccine: UNK, COVID19
Symptoms: Heavy menstrual bleeding, Menstrual disorder, Vaccination site bruising, Vaccination site erythema, Vaccination site induration
Clinical narrative: the injection site on her left arm was hard to the touch and has bruises; the injection site on her left arm was hard to the touch and has bruises; menstrual cycle and symptoms came earlier and heavier; menstrual cycle and symptoms came earlier and heavier; Second dose: the injection site on her left arm got really, really big, itchy, and it was hot to the touch; Second dose: the injection site on her left arm got really, really big, itchy, and it was hot to the touch; second dose of Pfizer-BioNTech COVID-19 Vaccine injection when area started getting red; This is a spontaneous report from a contactable consumer reporting for herself. A 36-year-old female patient receive second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration at the age of 36 years old on 08Apr2021 10:45 (Lot Number: EW0151, Expiration Date: 11Apr2021) on Left arm at single dose for COVID-19 immunization. Medical history was reported as none. Ongoing concomitant medications included curcuma longa (TURMERIC), fish oil (OMEGAN) and zinc, all as Herbal supplement. Historical Vaccine included first dose of BNT162B2 (lot number EN6207) at the age of 36 years old on 18Mar2021 on Left arm for COVID-19 immunization and experienced chills and injection site pain of the left arm. The patient reported that after that second dose her menstrual cycle and symptoms came earlier and heavier on 09Apr2021. She also reported that the injection site on her left arm got really, really big, itchy, and it was hot to the touch on 08Apr2021. Starting today (13Apr2021) the injection site on her left arm was hard to the touch and has bruises. She asked if these adverse events were normal. It was also reported onset was around 2-3 hours after she was administered the second dose of Pfizer-BioNTech COVID-19 Vaccine injection when area started getting red on 08Apr2021. The affected area got smaller and smaller. The outcome of events vaccination site pruritus, vaccination site warmth, vaccination site erythema were resolving while outcome of other events were unknown.   No follow-up attempts are needed. No further information is expected.
Age: 36.0
Sex: F
Vaccine: UNK, COVID19
Symptoms: Vaccination site pruritus, Vaccination site warmth
Clinical narrative: the injection site on her left arm was hard to the touch and has bruises; the injection site on her left arm was hard to the touch and has bruises; menstrual cycle and symptoms came earlier and heavier; menstrual cycle and symptoms came earlier and heavier; Second dose: the injection site on her left arm got really, really big, itchy, and it was hot to the touch; Second dose: the injection site on her left arm got really, really big, itchy, and it was hot to the touch; second dose of Pfizer-BioNTech COVID-19 Vaccine injection when area started getting red; This is a spontaneous report from a contactable consumer reporting for herself. A 36-year-old female patient receive second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration at the age of 36 years old on 08Apr2021 10:45 (Lot Number: EW0151, Expiration Date: 11Apr2021) on Left arm at single dose for COVID-19 immunization. Medical history was reported as none. Ongoing concomitant medications included curcuma longa (TURMERIC), fish oil (OMEGAN) and zinc, all as Herbal supplement. Historical Vaccine included first dose of BNT162B2 (lot number EN6207) at the age of 36 years old on 18Mar2021 on Left arm for COVID-19 immunization and experienced chills and injection site pain of the left arm. The patient reported that after that second dose her menstrual cycle and symptoms came earlier and heavier on 09Apr2021. She also reported that the injection site on her left arm got really, really big, itchy, and it was hot to the touch on 08Apr2021. Starting today (13Apr2021) the injection site on her left arm was hard to the touch and has bruises. She asked if these adverse events were normal. It was also reported onset was around 2-3 hours after she was administered the second dose of Pfizer-BioNTech COVID-19 Vaccine injection when area started getting red on 08Apr2021. The affected area got smaller and smaller. The outcome of events vaccination site pruritus, vaccination site warmth, vaccination site erythema were resolving while outcome of other events were unknown.   No follow-up attempts are needed. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Condition aggravated, Contusion, Headache, Hypersensitivity, Hypersomnia
Clinical narrative: Urticaria; throat still has pain; odd feeling; low blood pressure, hypotension 70-90; General malaise and ongoing; This is a spontaneous report from a contactable consumer (patient). A 49-years-old female patient received second dose of bnt162b2 (Formulation: Solution for injection, Batch/Lot Number: EN6205)) via an unspecified route of administration in left arm on 29Mar2021 at 14:45 as 2nd dose single for covid-19 immunisation. Medical history included asthma, hypothyroidism, insulin resistance. The patient's concomitant medications was not reported. Patient is not Pregnant at the time of vaccination, patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine, Prior to vaccination, the patient was not diagnosed with COVID-19, Since the vaccination, the patient has been tested for COVID-19 as Yes. Previously received BNT162B2 for COVID-19 im-munization (product COVID 19, lot number EL9269, administration date 08Mar2021, administra-tion time=02:45 PM, dose number 1, vaccine location Left arm). On 30Mar2021, the patient experienced Low blood pressure, hypotension 70-90, on unknown date in Apr2021, Throat "still has", pain, odd feeling and ongoing, on 02Apr2021 urticaria on several parts of the body, on 30Mar2021, General malaise and ongoing. ae resulted in emergency department. The patient underwent lab tests and procedures which included on 30Mar2021 hypotension 70-90 mmhg, on 29Mar2021, sars-cov-2 test: negative, on 30Mar2021 sars-cov-2 test: negative, on 07Apr2021, sars-cov-2 test: negative. No treatment received for the adverse events. The outcome of the events low blood pressure, hypotension 70-90 was resolved with sequel on Apr2021, throat still has pain, odd feeling, general malaise and ongoing was not recovered, urticaria was recovered on 03Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypotension, Laboratory test, Malaise, Oropharyngeal pain, Pain in extremity
Clinical narrative: Urticaria; throat still has pain; odd feeling; low blood pressure, hypotension 70-90; General malaise and ongoing; This is a spontaneous report from a contactable consumer (patient). A 49-years-old female patient received second dose of bnt162b2 (Formulation: Solution for injection, Batch/Lot Number: EN6205)) via an unspecified route of administration in left arm on 29Mar2021 at 14:45 as 2nd dose single for covid-19 immunisation. Medical history included asthma, hypothyroidism, insulin resistance. The patient's concomitant medications was not reported. Patient is not Pregnant at the time of vaccination, patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine, Prior to vaccination, the patient was not diagnosed with COVID-19, Since the vaccination, the patient has been tested for COVID-19 as Yes. Previously received BNT162B2 for COVID-19 im-munization (product COVID 19, lot number EL9269, administration date 08Mar2021, administra-tion time=02:45 PM, dose number 1, vaccine location Left arm). On 30Mar2021, the patient experienced Low blood pressure, hypotension 70-90, on unknown date in Apr2021, Throat "still has", pain, odd feeling and ongoing, on 02Apr2021 urticaria on several parts of the body, on 30Mar2021, General malaise and ongoing. ae resulted in emergency department. The patient underwent lab tests and procedures which included on 30Mar2021 hypotension 70-90 mmhg, on 29Mar2021, sars-cov-2 test: negative, on 30Mar2021 sars-cov-2 test: negative, on 07Apr2021, sars-cov-2 test: negative. No treatment received for the adverse events. The outcome of the events low blood pressure, hypotension 70-90 was resolved with sequel on Apr2021, throat still has pain, odd feeling, general malaise and ongoing was not recovered, urticaria was recovered on 03Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia, Throat irritation, Urticaria
Clinical narrative: Urticaria; throat still has pain; odd feeling; low blood pressure, hypotension 70-90; General malaise and ongoing; This is a spontaneous report from a contactable consumer (patient). A 49-years-old female patient received second dose of bnt162b2 (Formulation: Solution for injection, Batch/Lot Number: EN6205)) via an unspecified route of administration in left arm on 29Mar2021 at 14:45 as 2nd dose single for covid-19 immunisation. Medical history included asthma, hypothyroidism, insulin resistance. The patient's concomitant medications was not reported. Patient is not Pregnant at the time of vaccination, patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine, Prior to vaccination, the patient was not diagnosed with COVID-19, Since the vaccination, the patient has been tested for COVID-19 as Yes. Previously received BNT162B2 for COVID-19 im-munization (product COVID 19, lot number EL9269, administration date 08Mar2021, administra-tion time=02:45 PM, dose number 1, vaccine location Left arm). On 30Mar2021, the patient experienced Low blood pressure, hypotension 70-90, on unknown date in Apr2021, Throat "still has", pain, odd feeling and ongoing, on 02Apr2021 urticaria on several parts of the body, on 30Mar2021, General malaise and ongoing. ae resulted in emergency department. The patient underwent lab tests and procedures which included on 30Mar2021 hypotension 70-90 mmhg, on 29Mar2021, sars-cov-2 test: negative, on 30Mar2021 sars-cov-2 test: negative, on 07Apr2021, sars-cov-2 test: negative. No treatment received for the adverse events. The outcome of the events low blood pressure, hypotension 70-90 was resolved with sequel on Apr2021, throat still has pain, odd feeling, general malaise and ongoing was not recovered, urticaria was recovered on 03Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Feeling abnormal, Hypotension, Malaise, Oropharyngeal pain, SARS-CoV-2 test
Clinical narrative: Urticaria; throat still has pain; odd feeling; low blood pressure, hypotension 70-90; General malaise and ongoing; This is a spontaneous report from a contactable consumer (patient). A 49-years-old female patient received second dose of bnt162b2 (Formulation: Solution for injection, Batch/Lot Number: EN6205)) via an unspecified route of administration in left arm on 29Mar2021 at 14:45 as 2nd dose single for covid-19 immunisation. Medical history included asthma, hypothyroidism, insulin resistance. The patient's concomitant medications was not reported. Patient is not Pregnant at the time of vaccination, patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine, Prior to vaccination, the patient was not diagnosed with COVID-19, Since the vaccination, the patient has been tested for COVID-19 as Yes. Previously received BNT162B2 for COVID-19 im-munization (product COVID 19, lot number EL9269, administration date 08Mar2021, administra-tion time=02:45 PM, dose number 1, vaccine location Left arm). On 30Mar2021, the patient experienced Low blood pressure, hypotension 70-90, on unknown date in Apr2021, Throat "still has", pain, odd feeling and ongoing, on 02Apr2021 urticaria on several parts of the body, on 30Mar2021, General malaise and ongoing. ae resulted in emergency department. The patient underwent lab tests and procedures which included on 30Mar2021 hypotension 70-90 mmhg, on 29Mar2021, sars-cov-2 test: negative, on 30Mar2021 sars-cov-2 test: negative, on 07Apr2021, sars-cov-2 test: negative. No treatment received for the adverse events. The outcome of the events low blood pressure, hypotension 70-90 was resolved with sequel on Apr2021, throat still has pain, odd feeling, general malaise and ongoing was not recovered, urticaria was recovered on 03Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Urticaria
Clinical narrative: Urticaria; throat still has pain; odd feeling; low blood pressure, hypotension 70-90; General malaise and ongoing; This is a spontaneous report from a contactable consumer (patient). A 49-years-old female patient received second dose of bnt162b2 (Formulation: Solution for injection, Batch/Lot Number: EN6205)) via an unspecified route of administration in left arm on 29Mar2021 at 14:45 as 2nd dose single for covid-19 immunisation. Medical history included asthma, hypothyroidism, insulin resistance. The patient's concomitant medications was not reported. Patient is not Pregnant at the time of vaccination, patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine, Prior to vaccination, the patient was not diagnosed with COVID-19, Since the vaccination, the patient has been tested for COVID-19 as Yes. Previously received BNT162B2 for COVID-19 im-munization (product COVID 19, lot number EL9269, administration date 08Mar2021, administra-tion time=02:45 PM, dose number 1, vaccine location Left arm). On 30Mar2021, the patient experienced Low blood pressure, hypotension 70-90, on unknown date in Apr2021, Throat "still has", pain, odd feeling and ongoing, on 02Apr2021 urticaria on several parts of the body, on 30Mar2021, General malaise and ongoing. ae resulted in emergency department. The patient underwent lab tests and procedures which included on 30Mar2021 hypotension 70-90 mmhg, on 29Mar2021, sars-cov-2 test: negative, on 30Mar2021 sars-cov-2 test: negative, on 07Apr2021, sars-cov-2 test: negative. No treatment received for the adverse events. The outcome of the events low blood pressure, hypotension 70-90 was resolved with sequel on Apr2021, throat still has pain, odd feeling, general malaise and ongoing was not recovered, urticaria was recovered on 03Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test, Cardiac monitoring, Paraesthesia, Vision blurred
Clinical narrative: Tingling pins and needles on my hands; Blurred vision; This is a spontaneous report from a contactable consumer (patient) from COVAES. This 59-year-old non-pregnant female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number ER8733) via an unspecified route of administration in the left arm on 23Apr2021 at 11:30 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin and shellfish allergies, both from unknown dates and unknown if ongoing. The patient had not received any other vaccines in the four weeks prior to the COVID vaccine. Concomitant medications included prednisone from an unknown date for an unknown indication. The patient previously received the first dose of BNT162B2 (lot number not reported) on 02Apr2021 at 11:30 (at the age of 59-years-old) for COVID-19 immunisation. The patient reported the evening of her vaccination she noticed some blurred vision and tingling pins and needles on her hands on 23Apr2021 at 18:00. She reported that because she was concerned about it, she kept watch of it until she fell asleep and in the morning she called her doctor's office who suggested she go to the emergency room for possible neurological effects. The events required an emergency room and physician office visit. The clinical outcomes of blurred vision and tingling pins and needles on her hands were recovering. It was also reported that the patient had not been tested for COVID-19 since vaccination.   No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Paraesthesia, Vision blurred
Clinical narrative: Tingling pins and needles on my hands; Blurred vision; This is a spontaneous report from a contactable consumer (patient) from COVAES. This 59-year-old non-pregnant female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number ER8733) via an unspecified route of administration in the left arm on 23Apr2021 at 11:30 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin and shellfish allergies, both from unknown dates and unknown if ongoing. The patient had not received any other vaccines in the four weeks prior to the COVID vaccine. Concomitant medications included prednisone from an unknown date for an unknown indication. The patient previously received the first dose of BNT162B2 (lot number not reported) on 02Apr2021 at 11:30 (at the age of 59-years-old) for COVID-19 immunisation. The patient reported the evening of her vaccination she noticed some blurred vision and tingling pins and needles on her hands on 23Apr2021 at 18:00. She reported that because she was concerned about it, she kept watch of it until she fell asleep and in the morning she called her doctor's office who suggested she go to the emergency room for possible neurological effects. The events required an emergency room and physician office visit. The clinical outcomes of blurred vision and tingling pins and needles on her hands were recovering. It was also reported that the patient had not been tested for COVID-19 since vaccination.   No follow-up attempts are needed. No further information is expected.
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Rash
Clinical narrative: out-of breath; 1-1/2 days after injection began as rash on lower middle back-(looked like a picture of measles)-spread throughout entire body except for face/head over the next few days; moved into lungs-pressure; burning; This is a spontaneous report from a contactable consumer. A 64-year-old male patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Right on 21Apr2021 14:30 (Batch/Lot Number: ER8731) as 2nd dose, single (at the age of 64 years) for covid-19 immunisation. The patient's medical history included high blood pressure from an unknown date and unknown if ongoing. The patient has not had Covid-19 prior to vaccination. The patient has no known allergies. Concomitant medications included lisinopril; diltiazem; and cholestyramine, all taken for an unspecified indication, start and stop date were not reported. The patient received the first dose, an unspecified route of administration, administered in Arm Right on 31Mar2021 11:30 (Batch/Lot Number: ER8737) for covid-19 immunization.  On 23Apr2021 at 7:30, 1-1/2 days after injection began as rash on lower middle back-(looked like a picture of measles)-spread throughout entire body except for face/head over the next few days Despite treatment/testing at hospital has moved into lungs-pressure, burning and out of breath. It was reported that the events resulted to doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, and Hospitalization for 1 day.  The had testing and breathing med as treatment for the events. The patient underwent lab tests and procedures which included sars-cov-2 test (covid): negative  on 07May2021 via nasal swab. The outcome of the events was recovering.
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Burning sensation, Dyspnoea, Lung disorder, Rash, SARS-CoV-2 test
Clinical narrative: out-of breath; 1-1/2 days after injection began as rash on lower middle back-(looked like a picture of measles)-spread throughout entire body except for face/head over the next few days; moved into lungs-pressure; burning; This is a spontaneous report from a contactable consumer. A 64-year-old male patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Right on 21Apr2021 14:30 (Batch/Lot Number: ER8731) as 2nd dose, single (at the age of 64 years) for covid-19 immunisation. The patient's medical history included high blood pressure from an unknown date and unknown if ongoing. The patient has not had Covid-19 prior to vaccination. The patient has no known allergies. Concomitant medications included lisinopril; diltiazem; and cholestyramine, all taken for an unspecified indication, start and stop date were not reported. The patient received the first dose, an unspecified route of administration, administered in Arm Right on 31Mar2021 11:30 (Batch/Lot Number: ER8737) for covid-19 immunization.  On 23Apr2021 at 7:30, 1-1/2 days after injection began as rash on lower middle back-(looked like a picture of measles)-spread throughout entire body except for face/head over the next few days Despite treatment/testing at hospital has moved into lungs-pressure, burning and out of breath. It was reported that the events resulted to doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, and Hospitalization for 1 day.  The had testing and breathing med as treatment for the events. The patient underwent lab tests and procedures which included sars-cov-2 test (covid): negative  on 07May2021 via nasal swab. The outcome of the events was recovering.
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Angiogram, Cardiovascular evaluation, Chest X-ray normal, Chest discomfort, Drug eruption
Clinical narrative: out-of breath; 1-1/2 days after injection began as rash on lower middle back-(looked like a picture of measles)-spread throughout entire body except for face/head over the next few days; moved into lungs-pressure; burning; This is a spontaneous report from a contactable consumer. A 64-year-old male patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Right on 21Apr2021 14:30 (Batch/Lot Number: ER8731) as 2nd dose, single (at the age of 64 years) for covid-19 immunisation. The patient's medical history included high blood pressure from an unknown date and unknown if ongoing. The patient has not had Covid-19 prior to vaccination. The patient has no known allergies. Concomitant medications included lisinopril; diltiazem; and cholestyramine, all taken for an unspecified indication, start and stop date were not reported. The patient received the first dose, an unspecified route of administration, administered in Arm Right on 31Mar2021 11:30 (Batch/Lot Number: ER8737) for covid-19 immunization.  On 23Apr2021 at 7:30, 1-1/2 days after injection began as rash on lower middle back-(looked like a picture of measles)-spread throughout entire body except for face/head over the next few days Despite treatment/testing at hospital has moved into lungs-pressure, burning and out of breath. It was reported that the events resulted to doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, and Hospitalization for 1 day.  The had testing and breathing med as treatment for the events. The patient underwent lab tests and procedures which included sars-cov-2 test (covid): negative  on 07May2021 via nasal swab. The outcome of the events was recovering.
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dyspnoea, Rash papular
Clinical narrative: out-of breath; 1-1/2 days after injection began as rash on lower middle back-(looked like a picture of measles)-spread throughout entire body except for face/head over the next few days; moved into lungs-pressure; burning; This is a spontaneous report from a contactable consumer. A 64-year-old male patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Right on 21Apr2021 14:30 (Batch/Lot Number: ER8731) as 2nd dose, single (at the age of 64 years) for covid-19 immunisation. The patient's medical history included high blood pressure from an unknown date and unknown if ongoing. The patient has not had Covid-19 prior to vaccination. The patient has no known allergies. Concomitant medications included lisinopril; diltiazem; and cholestyramine, all taken for an unspecified indication, start and stop date were not reported. The patient received the first dose, an unspecified route of administration, administered in Arm Right on 31Mar2021 11:30 (Batch/Lot Number: ER8737) for covid-19 immunization.  On 23Apr2021 at 7:30, 1-1/2 days after injection began as rash on lower middle back-(looked like a picture of measles)-spread throughout entire body except for face/head over the next few days Despite treatment/testing at hospital has moved into lungs-pressure, burning and out of breath. It was reported that the events resulted to doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, and Hospitalization for 1 day.  The had testing and breathing med as treatment for the events. The patient underwent lab tests and procedures which included sars-cov-2 test (covid): negative  on 07May2021 via nasal swab. The outcome of the events was recovering.
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arterial thrombosis, Fatigue, Hypoaesthesia, Lymphadenopathy, Pain in extremity
Clinical narrative: Both sides of my neck were very swollen. There was extreme pain on my right arm. The pain was severe and numbness in my finger. I went to the ER and they said I have radial thrombus, a clot in the radial artery.  Before the shot, my heart was checked multiple times and I was fine. After the shot, my coronary arteries are now very small. There are now luminal changes inside my coronary arteries which are still now very small. I now have been diagnosed with CAD. I had a heart cath on March 29. My arm is still in a lot of pain. My neck is still swollen.
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cardiopulmonary exercise test, Catheterisation cardiac, Computerised tomogram, Coronary artery disease, Echocardiogram
Clinical narrative: Both sides of my neck were very swollen. There was extreme pain on my right arm. The pain was severe and numbness in my finger. I went to the ER and they said I have radial thrombus, a clot in the radial artery.  Before the shot, my heart was checked multiple times and I was fine. After the shot, my coronary arteries are now very small. There are now luminal changes inside my coronary arteries which are still now very small. I now have been diagnosed with CAD. I had a heart cath on March 29. My arm is still in a lot of pain. My neck is still swollen.
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Electrocardiogram, Hypoaesthesia, Microvascular coronary artery disease, Pain in extremity, Swelling
Clinical narrative: Both sides of my neck were very swollen. There was extreme pain on my right arm. The pain was severe and numbness in my finger. I went to the ER and they said I have radial thrombus, a clot in the radial artery.  Before the shot, my heart was checked multiple times and I was fine. After the shot, my coronary arteries are now very small. There are now luminal changes inside my coronary arteries which are still now very small. I now have been diagnosed with CAD. I had a heart cath on March 29. My arm is still in a lot of pain. My neck is still swollen.
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Thrombosis, Ultrasound scan
Clinical narrative: Both sides of my neck were very swollen. There was extreme pain on my right arm. The pain was severe and numbness in my finger. I went to the ER and they said I have radial thrombus, a clot in the radial artery.  Before the shot, my heart was checked multiple times and I was fine. After the shot, my coronary arteries are now very small. There are now luminal changes inside my coronary arteries which are still now very small. I now have been diagnosed with CAD. I had a heart cath on March 29. My arm is still in a lot of pain. My neck is still swollen.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Dizziness, Hypoaesthesia
Clinical narrative: Pt. felt very nauseated, dizzy, anxious , and hot sweats. Paramedics were called and took her vitals and all vitals where good. Pt. refused to go to hospital but she  did lie down for about 20 minutes and was given water. She walked out on her own power with husband.  Paramedics stated it was high anxiety that was probably causing the issues.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anxiety, Dizziness, Hot flush, Nausea
Clinical narrative: Pt. felt very nauseated, dizzy, anxious , and hot sweats. Paramedics were called and took her vitals and all vitals where good. Pt. refused to go to hospital but she  did lie down for about 20 minutes and was given water. She walked out on her own power with husband.  Paramedics stated it was high anxiety that was probably causing the issues.
Age: 20.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Angiogram, Chest pain, Dyspnoea, Fibrin D dimer increased, Laboratory test
Clinical narrative: Bilateral pulmonary emboli
Age: 20.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pulmonary embolism
Clinical narrative: Bilateral pulmonary emboli
Age: 20.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Angiogram pulmonary abnormal, Pulmonary embolism
Clinical narrative: Bilateral pulmonary emboli
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arthralgia, Axillary pain, Blood test normal, Breast tenderness, Computerised tomogram
Clinical narrative: Pt said after first dose lymph under arm felt swollen and experienced swelling. After receiving 2nd dose 2 weeks later she said her lymph system "blew up". She was in immense pain, had fluid retention and developed fluid blisters, experienced vision impairment and oil glands clogged in eyes, migraines, hair is falling out and fatigue.  Patient said doctor gave her high dose steroids. She is still being treated by doctor for this. Still having multiple symptoms and trying to get them under control.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Fatigue, Gastrointestinal disorder, Headache, Lymphadenopathy, Mammogram normal
Clinical narrative: Pt said after first dose lymph under arm felt swollen and experienced swelling. After receiving 2nd dose 2 weeks later she said her lymph system "blew up". She was in immense pain, had fluid retention and developed fluid blisters, experienced vision impairment and oil glands clogged in eyes, migraines, hair is falling out and fatigue.  Patient said doctor gave her high dose steroids. She is still being treated by doctor for this. Still having multiple symptoms and trying to get them under control.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pain, Pain in extremity, Pain in jaw, Scan with contrast, Swelling
Clinical narrative: Pt said after first dose lymph under arm felt swollen and experienced swelling. After receiving 2nd dose 2 weeks later she said her lymph system "blew up". She was in immense pain, had fluid retention and developed fluid blisters, experienced vision impairment and oil glands clogged in eyes, migraines, hair is falling out and fatigue.  Patient said doctor gave her high dose steroids. She is still being treated by doctor for this. Still having multiple symptoms and trying to get them under control.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Ultrasound scan
Clinical narrative: Pt said after first dose lymph under arm felt swollen and experienced swelling. After receiving 2nd dose 2 weeks later she said her lymph system "blew up". She was in immense pain, had fluid retention and developed fluid blisters, experienced vision impairment and oil glands clogged in eyes, migraines, hair is falling out and fatigue.  Patient said doctor gave her high dose steroids. She is still being treated by doctor for this. Still having multiple symptoms and trying to get them under control.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Alopecia, Blister, Dacryostenosis acquired, Fatigue, Fluid retention
Clinical narrative: Pt said after first dose lymph under arm felt swollen and experienced swelling. After receiving 2nd dose 2 weeks later she said her lymph system "blew up". She was in immense pain, had fluid retention and developed fluid blisters, experienced vision impairment and oil glands clogged in eyes, migraines, hair is falling out and fatigue.  Patient said doctor gave her high dose steroids. She is still being treated by doctor for this. Still having multiple symptoms and trying to get them under control.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Lymphadenopathy, Migraine, Pain, Visual impairment
Clinical narrative: Pt said after first dose lymph under arm felt swollen and experienced swelling. After receiving 2nd dose 2 weeks later she said her lymph system "blew up". She was in immense pain, had fluid retention and developed fluid blisters, experienced vision impairment and oil glands clogged in eyes, migraines, hair is falling out and fatigue.  Patient said doctor gave her high dose steroids. She is still being treated by doctor for this. Still having multiple symptoms and trying to get them under control.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Bone pain, Hypoaesthesia, Pain in extremity, Spinal pain
Clinical narrative: Systemic: back/spine pain-Medium
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Back pain, Spinal pain
Clinical narrative: Systemic: back/spine pain-Medium
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Fatigue, Headache, Muscle twitching, Thyroid function test
Clinical narrative: all over fasciculations; paresthesia in right arm and leg; deep lower back pain/shoulder pain; deep lower back pain/shoulder pain; This is a spontaneous report from a contactable consumer (patient). A 43-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Right on 23Apr2021 11:00 (Batch/Lot Number: ER8731) as 2nd dose, single, at the age of 43-years-old for COVID-19 immunization. The patient was not pregnant at the time of vaccination. Medical history included penicillin allergy. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 02Apr2021 10:30 lot number: EP7533, in the right arm. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. After second vaccine on 23Apr2021, on 26Apr2021 she noticed delayed onset of symptoms which include all over fasciculations, paresthesia in right arm and leg, deep lower back pain/shoulder pain. These symptoms have not resolved and are undiagnosed. Lumbar X-Ray came back normal, Creatine Kinase and CRP levels came back normal, neurological strength/reflex test presented normal. The events resulted in emergency room/department or urgent care. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. No treatment was given for the events. The outcome of the events was not recovered.   Follow up needed, further information has been requested.
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arthralgia, Back pain, Blood creatine phosphokinase, C-reactive protein, Muscle contractions involuntary
Clinical narrative: all over fasciculations; paresthesia in right arm and leg; deep lower back pain/shoulder pain; deep lower back pain/shoulder pain; This is a spontaneous report from a contactable consumer (patient). A 43-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Right on 23Apr2021 11:00 (Batch/Lot Number: ER8731) as 2nd dose, single, at the age of 43-years-old for COVID-19 immunization. The patient was not pregnant at the time of vaccination. Medical history included penicillin allergy. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 02Apr2021 10:30 lot number: EP7533, in the right arm. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. After second vaccine on 23Apr2021, on 26Apr2021 she noticed delayed onset of symptoms which include all over fasciculations, paresthesia in right arm and leg, deep lower back pain/shoulder pain. These symptoms have not resolved and are undiagnosed. Lumbar X-Ray came back normal, Creatine Kinase and CRP levels came back normal, neurological strength/reflex test presented normal. The events resulted in emergency room/department or urgent care. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. No treatment was given for the events. The outcome of the events was not recovered.   Follow up needed, further information has been requested.
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Paraesthesia, Reflex test, X-ray
Clinical narrative: all over fasciculations; paresthesia in right arm and leg; deep lower back pain/shoulder pain; deep lower back pain/shoulder pain; This is a spontaneous report from a contactable consumer (patient). A 43-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Right on 23Apr2021 11:00 (Batch/Lot Number: ER8731) as 2nd dose, single, at the age of 43-years-old for COVID-19 immunization. The patient was not pregnant at the time of vaccination. Medical history included penicillin allergy. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 02Apr2021 10:30 lot number: EP7533, in the right arm. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. After second vaccine on 23Apr2021, on 26Apr2021 she noticed delayed onset of symptoms which include all over fasciculations, paresthesia in right arm and leg, deep lower back pain/shoulder pain. These symptoms have not resolved and are undiagnosed. Lumbar X-Ray came back normal, Creatine Kinase and CRP levels came back normal, neurological strength/reflex test presented normal. The events resulted in emergency room/department or urgent care. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. No treatment was given for the events. The outcome of the events was not recovered.   Follow up needed, further information has been requested.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Feeling cold, Paraesthesia, Pharyngeal swelling
Clinical narrative: April 5th 10-15 minutes after dose:  tight throat and chest, congested, feeling out of it within 10-15 minutes after dose  Later that day:  tachycardia, burning sensation throughout body, tingling in nasal passage, arms and legs, lower back pain, lightheaded, joint pain, chills  April 6th additional symptoms to above and ongoing at various degrees: migrating shock sensation, cold extremities, swollen lymph nodes, shaking, ear ringing, fatigue, muscle cramping and stiffness, unsteady while sitting and standing, back weakness, periodic cough, nausea
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Asthenia, Back pain, Balance disorder, Burning sensation
Clinical narrative: April 5th 10-15 minutes after dose:  tight throat and chest, congested, feeling out of it within 10-15 minutes after dose  Later that day:  tachycardia, burning sensation throughout body, tingling in nasal passage, arms and legs, lower back pain, lightheaded, joint pain, chills  April 6th additional symptoms to above and ongoing at various degrees: migrating shock sensation, cold extremities, swollen lymph nodes, shaking, ear ringing, fatigue, muscle cramping and stiffness, unsteady while sitting and standing, back weakness, periodic cough, nausea
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Chills, Cough, Dizziness, Electric shock sensation
Clinical narrative: April 5th 10-15 minutes after dose:  tight throat and chest, congested, feeling out of it within 10-15 minutes after dose  Later that day:  tachycardia, burning sensation throughout body, tingling in nasal passage, arms and legs, lower back pain, lightheaded, joint pain, chills  April 6th additional symptoms to above and ongoing at various degrees: migrating shock sensation, cold extremities, swollen lymph nodes, shaking, ear ringing, fatigue, muscle cramping and stiffness, unsteady while sitting and standing, back weakness, periodic cough, nausea
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Feeling abnormal, Lymphadenopathy, Muscle spasms, Musculoskeletal stiffness
Clinical narrative: April 5th 10-15 minutes after dose:  tight throat and chest, congested, feeling out of it within 10-15 minutes after dose  Later that day:  tachycardia, burning sensation throughout body, tingling in nasal passage, arms and legs, lower back pain, lightheaded, joint pain, chills  April 6th additional symptoms to above and ongoing at various degrees: migrating shock sensation, cold extremities, swollen lymph nodes, shaking, ear ringing, fatigue, muscle cramping and stiffness, unsteady while sitting and standing, back weakness, periodic cough, nausea